![Thomas Greiner-Stöffele](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Greiner-Stöffele
Nessuna posizione attualmente
Storia della carriera di Thomas Greiner-Stöffele
Precedenti posizioni note di Thomas Greiner-Stöffele
Società | Posizione | Inizio | Fine |
---|---|---|---|
Universität Leipzig | Corporate Officer/Principal | 01/01/2008 | 01/01/2008 |
Max-Planck-Institute for Molecular Genetics | Corporate Officer/Principal | - | - |
c-LEcta GmbH
![]() c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany. | Direttore Tecnico/Scientifico/R&S | 01/10/2003 | - |
Fondatore | 19/11/2009 | - |
Formazione di Thomas Greiner-Stöffele
Universität Leipzig | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 4 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
c-LEcta GmbH
![]() c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany. | Health Technology |